Conclusion: Final Thoughts on Treatment Advances in NSCLC

In the final segment of a thirteen part series describing the optimal use of emerging and existing therapies for patients with non-small cell lung cancer, panelists emphasize several items of interest that were not previously mentioned during the discussion. To view the rest this discussion, visit http://www.onclive.com/peer-exchange/...